{
  "ticker": "LLY",
  "target_date": "2025-07-28",
  "actual_date": "2025-07-28",
  "collected_at": "2025-12-08T12:04:09.632064",
  "price": {
    "open": 809.68,
    "high": 817.22,
    "low": 799.57,
    "close": 805.156494140625,
    "volume": 2587700,
    "change_1d_pct": -0.56,
    "change_7d_pct": 6.12,
    "change_30d_pct": -0.48
  },
  "technicals": {
    "rsi_14": 58.93,
    "sma_20": 781.85,
    "sma_50": 769.63,
    "macd": 5.242,
    "macd_signal": 1.816,
    "macd_histogram": 3.426,
    "bb_upper": 811.13,
    "bb_lower": 752.57,
    "price_vs_sma20_pct": 2.98,
    "price_vs_sma50_pct": 4.62,
    "volume_ratio": 0.9
  },
  "fundamentals": {
    "market_cap": 891938668544,
    "pe_ratio": 48.748653,
    "forward_pe": 43.90821,
    "price_to_book": 37.460846,
    "price_to_sales": 15.010799,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.52,
    "pct_from_52w_low": 59.5
  },
  "macro": {
    "spy": {
      "price": 635.18,
      "change_1d_pct": -0.03,
      "change_7d_pct": 1.49
    },
    "vix": {
      "level": 15.03,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.42
    },
    "dollar_index": {
      "level": 98.66
    },
    "gold": {
      "price": 3309.1
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Analyst Highlights \u2018Game Changer\u2019 Catalyst for Eli Lilly (LLY)",
      "source": "Yahoo",
      "datetime": 1753733543,
      "summary": "Eli Lilly and Company (NYSE:LLY) is one of the Top 10 Stocks Wall Street is Buzzing About These Days. Talking about Morgan Stanley\u2019s bullish call on Eli Lilly and Company (NYSE:LLY), Kevin Simpson, Capital Wealth Planning founder and CIO, said that he agrees with the call and thinks the company\u2019s GL",
      "url": "https://finnhub.io/api/news?id=3ea17e31f7f44d2830604ae3a7685fce1044f6ecde84dd438364288616d7d451"
    },
    {
      "headline": "Healthcare Earnings Are Coming. 4 Big Questions for CVS, Humana, Merck, UnitedHealth, and More.",
      "source": "Yahoo",
      "datetime": 1753720800,
      "summary": "The healthcare sector, including managed-care firms and drug powerhouses, is vastly underperforming the S&P 500 index. Here are five problems they need to address.",
      "url": "https://finnhub.io/api/news?id=effbd36456b93069516cc1612f178c1d9cc51814939ac44278d6997b46475248"
    },
    {
      "headline": "Ireland's 'economic miracle' at risk from tariffs",
      "source": "Yahoo",
      "datetime": 1753719141,
      "summary": "The deal between the United States and the European Union may have averted a transatlantic trade war, but worries persist in Ireland where crucial sectors are dependent on US multinationals.But \"higher tariffs than there have been\" will make transatlantic trade \"more expensive and more challenging,\"",
      "url": "https://finnhub.io/api/news?id=911af6025161aa2888b29fa639255f8fa1f429694cfeff1a6653765f0e3232ed"
    },
    {
      "headline": "Biogen Gears Up to Report Q2 Earnings: Here's What to Expect",
      "source": "Yahoo",
      "datetime": 1753712640,
      "summary": "Biogen's Q2 results may show MS drug declines partially offset by gains from newer drugs.",
      "url": "https://finnhub.io/api/news?id=ae60b02c0449d28f4fff96c21b0e1eebd1c463a0d29e887217f207d5b258b2a4"
    },
    {
      "headline": "This is the Most Dangerous Week for Investors in 20 Years",
      "source": "Yahoo",
      "datetime": 1753711725,
      "summary": "This might be the most critical week for investors in years. In fact, in over two decades of investing, and more than a decade as a professional analyst, I\u2019ve never seen a single week with this many potentially market-moving headlines. Between earnings surprises, critical inflation and jobs data, a ",
      "url": "https://finnhub.io/api/news?id=3315ac2616db1af65296df57dceb135172d67259603dcb2c9d1869e150750af9"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-07-25",
      "description": "xslF345X05/form4-07252025_040701.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000141588925020284/xslF345X05/form4-07252025_040701.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753219662.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000196/xslF345X05/wk-form4_1753219662.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753217727.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000194/xslF345X05/wk-form4_1753217727.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753216439.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000188/xslF345X05/wk-form4_1753216439.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753215735.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000184/xslF345X05/wk-form4_1753215735.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}